Fast Five Medtech News Podcast

Analysts think GLP-1 drugs will have minor impact on insulin pump market and boost CGMs


Listen Later

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, September 12, 2023.
[Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast.]
Zeta Surgical recently announced it won FDA clearance for its mixed reality cranial surgical navigation system. Fast Five hosts Sean Whooley and Danielle Kirsh explain what the navigation system is and how it assists surgeons.
Centinel Spine announced last week that it is divesting its spine fusion business. Find out what the sale means for the company, when the deal will close and what executives think about this strategic move.
Surgical robotics are in the news again. Quantum Surgical won CE mark approval for its surgical robot that treats lung tumors. Whooley explains the purpose of the robot and what the expanded approval follows.
Philips has launched a new ultrasound technology to assist with cancer diagnostics. Learn what the technology does and why it is important for clinicians and patients.
Analysts think that GLP-1 drugs may have a minor impact on the insulin pump market but could boost the use of continuous glucose monitors. Whooley details what the impact could be and what analysts think about the impact of this class of pharmaceuticals on the insulin delivery market.
...more
View all episodesView all episodes
Download on the App Store

Fast Five Medtech News PodcastBy MassDevice